Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

Rodolfo Hanigan by Rodolfo Hanigan
March 25, 2026
in Analysis, Blockchain, Crypto Stocks, Market Commentary
0
Coinbase Stock
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

A legislative initiative in the U.S. Senate triggered a sharp decline in the value of Coinbase Global, Inc. stock during the latest trading session. The proposed CLARITY Act, championed by Senators Alsobrooks and Tillis, aims to prohibit platforms from offering returns on passive stablecoin holdings. This segment is a significant revenue driver for the crypto exchange, accounting for approximately one-fifth of its total income.

Market Impact and Broader Sector Pressure

The announcement sent shockwaves through the cryptocurrency sector. Coinbase shares plummeted roughly eleven percent, erasing billions in market capitalization as its valuation fell from $53.3 billion to about $47.7 billion. The news hit Circle Internet Financial, the issuer of the USDC stablecoin, even harder. Circle’s stock tumbled between 19 and 20 percent, closing near $101. Given the close operational ties between the two companies, Circle’s performance is often viewed as a direct sentiment gauge for Coinbase.

Other digital asset-adjacent equities also faced downward pressure. Trading platform Robinhood Markets, for instance, saw its shares drop 4.7 percent over the same period.

Deciphering the Legislative Threat

At its core, the draft legislation targets products that are economically or functionally equivalent to interest payments. Coinbase currently provides a 3.5 percent yield on USDC balances, while rivals Kraken and Binance offer returns ranging from 5 to 5.63 percent. The push for this regulation is backed by intensive lobbying from traditional banking institutions. These banks perceive such crypto-based yield products as unregulated competition for conventional deposit accounts.

Should investors sell immediately? Or is it worth buying Coinbase?

In a strategic move amid the uncertainty, Tether—the entity behind the USDT stablecoin—announced it would commission an audit from one of the “Big Four” accounting firms. Market observers interpret this as an attempt to secure market share while its primary competitor, USDC, faces regulatory scrutiny.

Divergent Views from Wall Street Analysts

Several market experts considered the sell-off an overreaction. Analysts from Clear Street and Mizuho noted that a ban on yield-generating products could actually benefit Coinbase in the near term by reducing its interest expense obligations. Peter Christiansen, an analyst at Citi, reaffirmed his “Buy” rating on the stock, maintaining a $400 price target.

The consensus price target among covering analysts currently stands at $266.15. Meanwhile, Argus Research has adopted a more cautious “Hold” stance, citing declining cryptocurrency prices and the company’s recent history of missing earnings estimates.

The ultimate trajectory of the CLARITY Act remains the critical variable for Coinbase in the coming weeks. Key questions surround the bill’s final language and whether exemptions for active user reward programs might be included.

Ad

Coinbase Stock: Buy or Sell?! New Coinbase Analysis from March 25 delivers the answer:

The latest Coinbase figures speak for themselves: Urgent action needed for Coinbase investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Coinbase: Buy or sell? Read more here...

Tags: Coinbase
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

Evolent Health Stock
AI & Quantum Computing

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock
AI & Quantum Computing

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock
Analysis

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026
Next Post
Ocugen Stock

Ocugen Shares Tumble Despite Positive Clinical Trial Results

Alphabet Stock

Regulatory Scrutiny Looms Over Alphabet's Aggressive AI Expansion

Oracle Stock

Oracle's Backlog Soars on Cloud and AI Contract Momentum

Recommended

Oracle Stock

Oracle Shares Face Sector-Wide Pressure Despite Solid Long-Term Chart

7 months ago
Telecommunications Industry stock Trading

Globalstar Forecasts Strong Financial Performance and Growth Initiatives for 2024

2 years ago
Pulmonx Corp Stock

Pulmonx Shares Surge on Leadership Shakeup and Upbeat Forecast

5 months ago
Healthcare-sector

Analysts Divided on GE HealthCare Technologies Evaluating the Potential of the Stock

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Hesai Group’s Milestone Profit Tempered by Cautious Guidance

PagerDuty Charts a New Course with Autonomous AI Systems

Trending

Evolent Health Stock
AI & Quantum Computing

Evolent Health Bets on AI Leadership Amid Share Price Decline

by Jackson Burston
March 25, 2026
0

The healthcare technology company Evolent Health is making a strategic push into artificial intelligence, appointing a seasoned...

MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026
Hain Celestial Stock

Hain Celestial Sheds Snack Division in Strategic Overhaul

March 25, 2026
Technology Select Sector SPDR® Fund Stock

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Evolent Health Bets on AI Leadership Amid Share Price Decline
  • MongoDB Strengthens Leadership Amid AI-Driven Growth Phase
  • Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com